Angela Lewis
Acute Care · Dallas, TXNPI 1912618943
Payments from drug & device makers
Across 123 payments — averaging $19.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$567
- Phathom Pharmaceuticals, Inc.$323
- Regeneron Healthcare Solutions, Inc.$322
- Lilly USA, LLC$176
- Sanofi$166
- Takeda Pharmaceuticals U.S.A., Inc.$156
- plus $627 from 13 others
What the payments were for
- Food & beverage$2,337100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 34 | $567 |
| Phathom Pharmaceuticals, Inc. | 25 | $323 |
| Regeneron Healthcare Solutions, Inc. | 11 | $322 |
| Lilly USA, LLC | 8 | $176 |
| Sanofi | 7 | $166 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $156 |
| Ardelyx, Inc. | 7 | $152 |
| Johnson & Johnson | 8 | $139 |
| Celltrion USA Inc. | 3 | $80 |
| Aimmune Therapeutics, Inc. | 3 | $53 |
| Intercept Pharmaceuticals, Inc. | 2 | $44 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $37 |
| Pfizer | 2 | $32 |
| Merck | 1 | $20 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
| Evoke Pharma, Inc. | 1 | $14 |
| Medtronic | 1 | $14 |
| Madrigal Pharmaceuticals | 1 | $13 |
| Organon | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VOQUEZNA$133
How this compares
$2,337 in reported general payments places this provider in the 85th percentile of 2,323 acute care providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 18 | $339 |
| Pantoprazole Sodium | 25 | $213 |
Paid to pharmacies, not to this prescriber.
Other acute care in Dallas
- Jennifer PilotteDallas$232K
- Amanda BradleyDallas$85K
- Martha LibertyDallas$28K
- Rachael SchneiderDallas$20K
- Peter TriporoDallas$15K
- Mario PadillaDallas$13K
- Toni SmithDallas$10K
- Christie MorrisonSan Antonio$225K
- Laura WilsonEl Paso$32K
- Kim HuynhCypress$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.